Bio-Works Technologies AB (publ)

Stockholm Stock Exchange BIOWKS.ST

Bio-Works Technologies AB (publ) Shares (Diluted, Weighted) for the year ending December 31, 2023: 36,113,273

Bio-Works Technologies AB (publ) Shares (Diluted, Weighted) is 36,113,273 for the year ending December 31, 2023, a 3.16% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Bio-Works Technologies AB (publ) Shares (Diluted, Weighted) for the year ending December 31, 2022 was 35,005,713, a 12.17% change year over year.
Bio-Works Technologies AB (publ) Shares (Diluted, Weighted) for the year ending December 31, 2021 was 31,206,413, a 2.60% change year over year.
Bio-Works Technologies AB (publ) Shares (Diluted, Weighted) for the year ending December 31, 2020 was 30,415,746, a 1.00% change year over year.
Bio-Works Technologies AB (publ) Shares (Diluted, Weighted) for the year ending December 31, 2019 was 30,114,657, a 49.22% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Stockholm Stock Exchange: BIOWKS.ST

Bio-Works Technologies AB (publ)

CEO	Ms. Lone Carlbom
IPO Date	Dec. 14, 2017
Location	Sweden
Headquarters	Virdings allé 18
Employees	35
Sector	Materials
Industries Plastics Biotechnology Chemicals & Advanced Materials Cleaning Supplies Containers & Packaging Personal Care Silver Vaccines

Description

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Key trends

Past 5 years